Joel F. Martin
President & Chief Executive Officer
Pharmaceutical Technology
Dauntless Pharmaceuticals
Canada
Biography
Joel F. Martin, PhD, is our President and Chief Executive Officer (CEO), a co-founder, and serves on our Board of Directors. From 2013 to January 2015, Dr. Martin was the President and CEO of Cebix Incorporated, a company that advanced a diabetes drug rapidly through a large, international Phase 2b trial. From 2008 to 2010, Dr. Martin was President and CEO of Altair Therapeutics, a Phase 2 asthma company that was acquired in 2010.
Research Interest
Pharmaceutical Products,pharma research.
